|
| |
BialIn a time characterised by globalisation, the international dimension of Bial is playing an ever greater role in the group’s strategic objectives. Being part of the global market and responding to the needs of the people in an ever larger number of world regions is an essential part of Bial’s commitment to Society.
Bial is today an International Pharmaceutical Group. Our products are to be found in pharmacies in nearly 30 countries in 4 continents: Europe, America, Africa and Asia. Whether in Spain or in the Dominican Republic, Portugal or Mozambique, Cyprus, Senegal or Ecuador, the members of the Bial Group and its representatives always strive to serve and satisfy health professionals and the general public. Some of the group companies are: Laboratórios Bial, Medibial, Bialfar, Bialport, Bial Aristegui, Medimport and Medangol.
| Contact Details: |
| |
| |
| |
| |
| |
| Tel: | 351 22 986 6100 |
| Fax: | 351 22 986 6190 |
| Email: | info@bial.com |
| WWW: | www.bial.com/
|
| |
Recent Publications by Bial: |  |
Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
Background: Nebicapone is a reversible catechol-O-methyltransferase (COMT)... | 20th November, 2009
| Department of Research and Development, BIAL (Portela & Ca., S.A.), S.
| Clin Ther. 2009 Oct;31(10):2258-2271.
DOI Direct Link |
Effect of questionnaire structure on recall of drug utilization in a population of university students.
BACKGROUND: Self-reported data are a common source of information about... | 11th November, 2009
| Department of Hygiene and Epidemiology, University of Porto Medical
| BMC Med Res Methodol. 2009 Jun 29;9:45.
DOI Direct Link |
Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
Eslicarbazepine acetate (ESL) is a new-generation voltage-gated sodium... | 31st October, 2009
| Department of Research and Development, BIAL - Portela & Co, SA, S Mamede
| Fundam Clin Pharmacol. 2009 Aug;23(4):509-14. Epub 2009 Jun 4.
DOI Direct Link |
Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
BACKGROUND: Specifically designed recombinant allergens with reduced IgE... | 31st October, 2009
| Bial-Aristegui, Research & Development Department, Bilbao, Spain.
| Clin Exp Allergy. 2009 Jul;39(7):1088-98. Epub 2009 Apr 21.
DOI Direct Link |
Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone.
The present study was designed to characterize pharmacodynamic and... | 20th October, 2009
| Department of Research and Development, BIAL, 4745-457 S. Mamede do
| Biochem Pharmacol. 2009 Oct 15;78(8):1043-51. Epub 2009 Jun 6.
DOI Direct Link |
→View more Bial research publications. |
Press Releases on Bial:
|
 |
| Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union |
28th April, 2009 |
|
S.MAMEDE DO CORONADO, Portugal and LONDON, April 28 /PRNewswire/ -- Bial-Portela & CA, S.A., (S. Mamede do Coronado, Portugal,
President & CEO Dr Luis Portela), and Eisai Europe Limited
|
| Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R) |
19th February, 2009 |
|
LONDON, February 19 /PRNewswire/ -- Eisai Europe Ltd (London; Chairman & CEO Yutaka Tsuchiya), the
European subsidiary of Eisai Co., Ltd. (Tokyo, President & CEO: Haruo Naito),
and Bial
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 13 individuals from Bial using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 3649 times since April 2007, the link to the organisation's website has been followed 748 times Recent Search Terms used to find this page: bial eslicarbazepine | BIAL pharma | bial pharmacuticals | bial aristegui pharmaceutical | bial pharmaceuticals | BIAL pharmaceutical | bial pharmaceuticals | bial pharmaceuticals | Laboratoris Bial Portela Co. Ltd. | bial pharmaceuticals | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Bial |
